Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:CTLT

Catalent (CTLT) Stock Price, News & Analysis

Catalent logo

About Catalent Stock (NYSE:CTLT)

Advanced Chart

Key Stats

Today's Range
$63.48
$63.48
50-Day Range
$59.66
$63.48
52-Week Range
$57.45
$63.50
Volume
N/A
Average Volume
2.06 million shs
Market Capitalization
$11.52 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$63.50
Consensus Rating
Hold

Company Overview

Catalent Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
21st Percentile Overall Score

CTLT MarketRank™: 

Catalent scored higher than 21% of companies evaluated by MarketBeat, and ranked 844th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Catalent has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Catalent has received no research coverage in the past 90 days.

  • Read more about Catalent's stock forecast and price target.
  • Earnings Growth

    Earnings for Catalent are expected to grow by 73.08% in the coming year, from $0.78 to $1.35 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Catalent is -28.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Catalent is -28.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Catalent has a PEG Ratio of 2.69. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Catalent has a P/B Ratio of 3.19. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for CTLT.
  • Dividend Yield

    Catalent does not currently pay a dividend.

  • Dividend Growth

    Catalent does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for CTLT.
    Receive CTLT Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Catalent and its competitors with MarketBeat's FREE daily newsletter.

    CTLT Stock News Headlines

    Which Gold Miner Trades at 30% of NAV? The One Buffett Wants
    Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. With gold at record highs and Bridgewater now buying in, one analyst believes Buffett’s next move could hit by August 15th. He’s identified the gold miner that fits Buffett’s profile — plus four smaller plays with even more upside.
    Lisata Therapeutics signs research license with Catalent
    Catalent Announces New Board Appointments
    See More Headlines

    CTLT Stock Analysis - Frequently Asked Questions

    Catalent, Inc. (NYSE:CTLT) announced its quarterly earnings results on Tuesday, November, 5th. The company reported ($0.13) EPS for the quarter, missing the consensus estimate of $0.05 by $0.18. Catalent's revenue for the quarter was up 4.2% compared to the same quarter last year.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Catalent investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Exxon Mobil (XOM).

    Company Calendar

    Last Earnings
    11/05/2024
    Today
    7/12/2025
    Fiscal Year End
    6/30/2026

    Industry, Sector and Symbol

    Stock Exchange
    NYSE
    Sector
    Medical
    Industry
    Pharmaceutical preparations
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NYSE:CTLT
    CIK
    1596783
    Employees
    16,900
    Year Founded
    N/A

    Price Target and Rating

    High Price Target
    $63.50
    Low Price Target
    $63.50
    Potential Upside/Downside
    +0.0%
    Consensus Rating
    Hold
    Rating Score (0-4)
    2.00
    Research Coverage
    3 Analysts

    Profitability

    EPS (Trailing Twelve Months)
    ($2.26)
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    81.38
    P/E Growth
    2.69
    Net Income
    -$1.04 billion
    Net Margins
    -9.28%
    Pretax Margin
    -7.83%
    Return on Equity
    -0.66%
    Return on Assets
    -0.24%

    Debt

    Debt-to-Equity Ratio
    1.38
    Current Ratio
    2.51
    Quick Ratio
    1.96

    Sales & Book Value

    Annual Sales
    $4.38 billion
    Price / Sales
    2.63
    Cash Flow
    $2.64 per share
    Price / Cash Flow
    24.04
    Book Value
    $19.91 per share
    Price / Book
    3.19

    Miscellaneous

    Outstanding Shares
    181,510,000
    Free Float
    180,949,000
    Market Cap
    $11.52 billion
    Optionable
    Optionable
    Beta
    1.15

    Social Links

    A Beginner's Guide to Investing in Cannabis Cover

    Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

    Get This Free Report

    This page (NYSE:CTLT) was last updated on 7/12/2025 by MarketBeat.com Staff
    From Our Partners